Key result
Triamterene plus furosemide normalizes potassium and blood pressure in pediatric low-renin hypertension.
Why the study?
Low-renin hypertension with abnormal cortisol metabolism in very young children is rare and not well characterized.
Case Report (n=1)
Triamterene combined with furosemide successfully managed low-renin, low-aldosterone hypertension and hypokalaemia in a pediatric patient with abnormal cortisol metabolism.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for diuretic therapy in pediatric low-renin hypertension; prospective trials needed before clinical adoption.
A 19-month-old boy presented with failure to thrive and polydipsia. Low-renin hypertension was diagnosed by the presence of hypertension, hypokalaemic alkalosis, suppressed plasma renin activity and low plasma aldosterone. Plasma levels and urinary excretion of other mineralocorticoids and glucocorticosteroids were low or normal. Urinary tetrahydrocortisol (THF) was increased relative to tetrahydrocortisone (THE) and also the plasma cortisol to cortisone ratio was elevated. These findings are suggestive of a decreased activity of cortisol-11 beta-hydroxysteroid dehydrogenase. Hypertension and hypokalaemia were not influenced by spironolactone and dexamethasone. Triamterene normalised serum potassium, but addition of furosemide was required for lowering blood pressure. With this treatment catch-up growth was observed.
No takes yet. Share an insight, caveat, or question.
Fiselier et al. (2008) conducted a case report in Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism (n=1). Triamterene and furosemide was evaluated on Blood pressure and serum potassium normalization. Treatment with triamterene normalized serum potassium, and the addition of furosemide lowered blood pressure, leading to catch-up growth in a child with low-renin hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: